For the first time, it was functionally and mechanistically demonstrated that CASC11 drove HCC progression by recruiting EIF4A3 to regulate E2F1 affecting HCC cells proliferation, cell mobility, apoptosis, and cellular metabolism in vitro and in vivo. This evidence concerns the gene E2F1 and hepatocellular carcinoma.